Microtubule stabilising agents for cancer chemotherapy

By Zhao Ying   Fang Wei-Shuo   Pors Klaus  

Expert Opinion on Therapeutic Patents, Vol. 19, Iss. 5, 2009-05 ,pp. : 607-622

Informa Healthcare

Access to resources Recommend Favorite

Epothilones: novel microtubule-stabilising agents

By Bollag D.M.  

Expert Opinion on Investigational Drugs, Vol. 6, Iss. 7, 1997-07 ,pp. : 867-874

Informa Healthcare

Access to resources Recommend Favorite

Microtubule-stabilising drugs for therapy of Alzheimer’s disease and other neurodegenerative disorders with axonal transport impairments

By Trojanowski John Q   Smith Amos B   Huryn Donna   Lee Virginia M-Y  

Expert Opinion on Pharmacotherapy, Vol. 6, Iss. 5, 2005-05 ,pp. : 683-686

Informa Healthcare

Access to resources Recommend Favorite

3D QSAR Models of Interactions Between &bgr;-Tubulin and Microtubule Stabilizing Antimitotic Agents (MSAA): A Survey on Taxanes and Epothilones

By  

Current Topics in Medicinal Chemistry, Vol. 4, Iss. 2, 2004-01 ,pp. : 203-217

Bentham Science Publishers

Access to resources Recommend Favorite

3D QSAR studies for the -tubulin binding site of microtubule-stabilizing anticancer agents (MSAAs) - A pseudoreceptor model for taxanes based on the experimental structure of tubulin

By Maccari L.   Manetti F.   Corelli F.   Botta M.  

Il Farmaco, Vol. 58, Iss. 9, 2003-09 ,pp. : 659-668

Elsevier

Access to resources Recommend Favorite